vedolizumab-irdye800cw
Showing 1 - 1 of 1
Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)
Not yet recruiting
- Age-Related Macular Degeneration
- Bevacizumab-IRDye800CW
- Vedolizumab-IRDye800CW
- (no location specified)
May 19, 2022